Optime Care Continues Growth in St. Louis, Supports Patients with Rare Diseases
EARTH CITY, Mo.--(BUSINESS WIRE)--Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces continued staff expansion at its St. Louis operation to meet client demand. The company now employs 66 people, an increase of 200% from 2015 when operations began.
“Our corporate footprint in the St. Louis market is expanding rapidly, and we continue to not only upgrade our current facility but also expand our staff as we reaffirm our commitment to partnering with biotech/pharmaceutical manufacturers for new rare and orphan disease product launches and serving patients within this region and nationally,” says Tiffany Burt, president and COO, Optime Care.
Optime Care’s leadership team has been transforming the rare and orphan drug space since 1999, having partnered with major pharmaceutical manufacturers to launch, manage and transition over 40 successful biopharmaceutical programs while continuing to ensure optimal outcomes for patients. All treatment programs are led by a team of dedicated individuals who develop personalized relationships with each patient, resulting in increased compliancy to therapy and improved outcomes.
A rare disease in the U.S. is a disorder impacting fewer than 200,000 people or about one in 10 Americans.
Optime Care, a subsidiary of AscellaHealth, has several strategies for achieving more efficient rare and orphan drug market access. These include:
- Providing Early Insights/Crafting Payer and Market Strategy: Optime Care works collaboratively with manufacturers to create an effective payer strategy that reflects an appreciation of the market forces and insight into a drug's value and competitive landscape. The team relies on an expert market access team that can partner on a project basis or function as an outsourced unit to address market access challenges.
- Developing Effective Distribution Strategy: Optime Care has an exclusive distribution model which ensures optimal product access for patients while providing financial benefits for manufacturers. Limited Distribution Drug Fulfillment also provides wholesale, 3PL, distribution and high-touch services that span national fulfillment of all Specialty Pharmacy medications with enhanced transparency and call center resources.
Read more about the integrated, customized approach for specialty drugs here.
About Optime Care
Optime Care, Inc. is a nationally recognized specialty pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders. Our executive team has partnered in launching and managing over 40 orphan products and programs while consistently implementing the best brand services for the community. Our experience with small patient populations, coupled with our strategic partnership with AscellaHealth, enhances our services and ability to serve he specialty pharmacy market. Optime Care has dual accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with a specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers. https://www.optimecare.com/
201.641.1911 x 21